In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

Three speakers outlined how AI is likely to have a major impact on the future of preventive cardiology.At the American ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

Rare cancers make up one in four cancer diagnoses in the U.S., yet many of them lack a standardized procedure of care for ...

Despite increased public awareness and improved treatment for irritable bowel syndrome, symptoms of IBS continue to disrupt ...